Nav: Home

New method grows brain cells from stem cells quickly and efficiently

August 22, 2018

Researchers at Lund University in Sweden have developed a faster method to generate functional brain cells, called astrocytes, from embryonic stem cells. Astrocytes play a significant role in neurodegenerative diseases. The new method reduces the time required to produce the cells from months to two weeks, and the study has been published in Nature Methods.

"This means that it is now easier than before to study the role of astrocytes in various diseases", says Henrik Ahlenius, who led the research team.

Even though the presence in our brain of the star-shaped glial cells, known as astrocytes, has been known for a long time, it has only recently been discovered how significant these brain cells actually are. Instead of only having a support function, as previously thought, the cells play an important role in the normal brain and in conditions such as dementia diseases and ALS.

One challenge that researchers have faced is the difficulty in obtaining human astrocytes to study. There are ways to grow astrocytes in the lab, but it has taken a long time and proved difficult, expensive and complicated. Until now.

"Previous methods have succeeded in producing human astrocytes from embryonic stem cells, but it has taken months. Using our method, it takes one to two weeks to produce large amounts of fully functional human astrocytes", says Henrik Ahlenius.

Simply put, Henrik Ahlenius and his research team show how it is possible to use viruses to activate genes in the embryonic stem cells, which during normal development regulate how the astrocytes are formed. In this way, the researchers have succeeded in making the embryonic stem cells rapidly form astrocytes.

"Many researchers have previously used embryonic stem cells to generate astrocytes, but these methods have attempted to mimic the normal development of an embryo's stem cell when developing an astrocyte in an individual, which requires a time-consuming and complicated approach", says Henrik Ahlenius.

The astrocytes produced from the embryonic stem cells are very similar to the astrocytes in the brain of adult humans, in terms of appearance, genetic profile and function.

The cells' use in studying diseases of the brain has been shown by the research team through employing CRISPR-Cas9, popularly known as gene editing, to insert a mutation in the embryonic stem cells that gives rise to the serious brain condition Alexander disease. They subsequently used the new method to change healthy and mutated stem cells into astrocytes.

When the researchers compared the astrocytes, it was shown that cells with the mutation exhibited several defects previously known to be present among those suffering from Alexander disease. "Using this approach of combining CRISPR-Cas9 and our method to rapidly grow human astrocytes provides improved possibilities to study the role of astrocytes in various neurological diseases", says Henrik Ahlenius.

The research team's main focus is studying age-related neurodegenerative diseases such as dementia and Alzheimer's, and the next step will be to use the method to examine the significance of astrocytes in these diseases.
-end-


Lund University

Related Embryonic Stem Cells Articles:

New insights into mechanisms regulating gene expression in embryonic stem cells
Researchers from Turku, Finland, have discovered new information about the mechanisms which maintain gene activity in human embryonic stem cells.
New tools to study the origin of embryonic stem cells
Researchers at Karolinska Institutet have identified cell surface markers specific for the very earliest stem cells in the human embryo.
Scientists approve the similarity between reprogrammed and embryonic stem cells
Researchers from the Vavilov Institute of General Genetics, Research Institute of Physical Chemical Medicine and Moscow Institute of Physics and Technology (MIPT) have concluded that reprogramming does not create differences between reprogrammed and embryonic stem cells.
Drug makes stem cells become 'embryonic' again
If you want to harness the full power of stem cells, all you might need is an eraser -- in the form of a drug that can erase the tiny labels that tell cells where to start reading their DNA.
Oncogene controls stem cells in early embryonic development
Many animal species delay the development of their embryos to ensure that their offspring is born at a favorable time.
More Embryonic Stem Cells News and Embryonic Stem Cells Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Teaching For Better Humans
More than test scores or good grades — what do kids need to prepare them for the future? This hour, guest host Manoush Zomorodi and TED speakers explore how to help children grow into better humans, in and out of the classroom. Guests include educators Olympia Della Flora and Liz Kleinrock, psychologist Thomas Curran, and writer Jacqueline Woodson.
Now Playing: Science for the People

#535 Superior
Apologies for the delay getting this week's episode out! A technical glitch slowed us down, but all is once again well. This week, we look at the often troubling intertwining of science and race: its long history, its ability to persist even during periods of disrepute, and the current forms it takes as it resurfaces, leveraging the internet and nationalism to buoy itself. We speak with Angela Saini, independent journalist and author of the new book "Superior: The Return of Race Science", about where race science went and how it's coming back.